Why the study?
Does pericardo-pleural window by VATS improve outcomes and reduce recurrence compared to pericardocentesis in patients with neoplastic pericarditis?
Does pericardo-pleural window by VATS improve outcomes and reduce recurrence compared to pericardocentesis in patients with neoplastic pericarditis?
Thoracoscopic pericardo-pleural window is a more effective surgical treatment with lower recurrence rates than pericardocentesis for managing malignant pericardial effusion.
The immediate prognosis of the patient with malignant pericardial effusion is influenced by the risk of postoperative Low-Cardiac-Output-Syndrome (LCOS), or pericardial decompression syndrome (PDS), which remains the main cause of mortality. The long-term prognosis is related to the type of malignant tumor. The most effective tehnique with the lowest rate of recurrence is pericardo-pleural window done thoracoscopically/ by VATS; pericardocentesis has the highest rate of recurrence - 90% and is associated with high rates of cardiac complications and mortality.
No takes yet. Share an insight, caveat, or question.
Jianu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: